tetano
Editor, Senior Moderator
Expert Rev Anti Infect Ther
. 2021 Apr 12;1-13.
doi: 10.1080/14787210.2021.1912593. Online ahead of print.
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2
Masoumeh Sadat Mousavi Maleki[SUP] 1 [/SUP], Mosayeb Restamian[SUP] 2 [/SUP], Hamid Madanchi[SUP] 1 3 [/SUP]
Affiliations
Abstract
Introduction: There are currently no specific drugs and universal vaccines for Coronavirus disease 2019 (COVID-19), hence urgent effective measures are needed to discover and develop therapeutic agents. Applying peptide therapeutics and their related compounds is a promising strategy to achieve this goal. This review is written based on the literature search using several databases, previous studies, scientific reports, our current knowledge about the antimicrobial peptides (AMPs), and our personal analyses on the potential of the antiviral peptides for the treatment of COVID-19.Areas covered: In this review, we begin with a brief description of SARS-CoV2 followed by a comprehensive description of antiviral peptides (AVPs) including natural and synthetic AMPs or AVPs and peptidomimetics. Subsequently, the structural features, mechanisms of action, limitations, and therapeutic applications of these peptides are explained.Expert opinion: Regarding the lack and the limitations of drugs against COVID-19, AMPs, AVPs, and other peptide-like compounds such as peptidomimetics have captured the attention of researchers due to their potential antiviral activities. Some of these compounds comprise unique properties and have demonstrated the potential to fight SARS-CoV2, particularly melittin, lactoferrin, enfuvirtide, and rupintrivir that have the potential to enter animal and clinical trials for the treatment of COVID-19.
Keywords: COVID-19; SARS-CoV-2; antimicrobial peptides; antiviral Peptides; peptidomimetics.
. 2021 Apr 12;1-13.
doi: 10.1080/14787210.2021.1912593. Online ahead of print.
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2
Masoumeh Sadat Mousavi Maleki[SUP] 1 [/SUP], Mosayeb Restamian[SUP] 2 [/SUP], Hamid Madanchi[SUP] 1 3 [/SUP]
Affiliations
- PMID: 33844613
- DOI: 10.1080/14787210.2021.1912593
Abstract
Introduction: There are currently no specific drugs and universal vaccines for Coronavirus disease 2019 (COVID-19), hence urgent effective measures are needed to discover and develop therapeutic agents. Applying peptide therapeutics and their related compounds is a promising strategy to achieve this goal. This review is written based on the literature search using several databases, previous studies, scientific reports, our current knowledge about the antimicrobial peptides (AMPs), and our personal analyses on the potential of the antiviral peptides for the treatment of COVID-19.Areas covered: In this review, we begin with a brief description of SARS-CoV2 followed by a comprehensive description of antiviral peptides (AVPs) including natural and synthetic AMPs or AVPs and peptidomimetics. Subsequently, the structural features, mechanisms of action, limitations, and therapeutic applications of these peptides are explained.Expert opinion: Regarding the lack and the limitations of drugs against COVID-19, AMPs, AVPs, and other peptide-like compounds such as peptidomimetics have captured the attention of researchers due to their potential antiviral activities. Some of these compounds comprise unique properties and have demonstrated the potential to fight SARS-CoV2, particularly melittin, lactoferrin, enfuvirtide, and rupintrivir that have the potential to enter animal and clinical trials for the treatment of COVID-19.
Keywords: COVID-19; SARS-CoV-2; antimicrobial peptides; antiviral Peptides; peptidomimetics.